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Lechocardiography, a more reliable and reproducible method
for quantifying MR.8 This is an important limitation be-
cause it is the precise degree of MR that is being placed into
the equation of analysis for the patient’s long-term survival.
In this era, echocardiography should be the standard for the
diagnosis and evaluation of functional MR.
Additionally, the authors’ conclusion that there was
“progression of the MR” in their patients is difficult to
substantiate because less than one third of the patients had
any echocardiographic follow-up. In fact, this circumstance
might have led to skewing of the follow-up dataset because
those patients with more congestive heart failure might have
been more likely to have been followed with echocardiog-
raphy. Problematically, there is also a lack of granularity in
Dr Mallidi’s analysis of preoperative ventricular function
and clinical status. Because more than half of the patients
had ejection fractions of greater than 40%, it is confusing
why almost 89% of the patients without any MR were
preoperatively categorized in New York Heart Association
class 3 or 4. From this dataset, it still remains unanswered
whether those patients with reduced ventricular function
had poorer outcomes. This is an especially important ques-
tion because it is those patients who are the most important
in this discussion. As Dr Gorman pointed out in his com-
mentary on the Tolis article, ischemic MR can be thought of
as the “ventricle crying out for help.”9
The article by Mallidi and colleagues1 adds to our knowl-
edge as we attempt to deal with this difficult clinical choice.
Our research efforts should remain focused on those pa-
tients with impaired ventricular function, the “sows’ ears”The Journal of Thoracithis patient subset that we might have the capability to
improve outcomes. The question still remains open: In
which patients and with what degree of ischemic MR will
intervention provide improved survival, thereby justifying
an added risk to the operative procedure?
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